Product dossierBuilt from registrations, label text and platform-curated data

汇美迪斯株式会社Humedix Co., Ltd.注射用交联透明质酸钠凝胶Pre-filled Cross-linked Sodium Hyaluronate Syringe

汇美迪斯株式会社Humedix Co., Ltd. is a Hyaluronic acid filler product (Class III device), registered by 汇美迪斯株式会社Humedix Co., Ltd.. Linked registrations: China 国械注进20263130223. First approved in China on 2026-06-16 (国械注进20263130223). Data as of 2026-10-24.

  • Regulatory classHyaluronic acid filler · Class III device
  • Holder汇美迪斯株式会社Humedix Co., Ltd.
  • JurisdictionsCN
  • Updated2026-10-24 · v1

Registration and basics are public; findings and prices need an account

Registration and basics

汇美迪斯株式会社Humedix Co., Ltd.

Product
Regulatory class
Class III device
Category
Hyaluronic acid filler
China · NMPA device registration
国械注进20263130223
Name on registration
注射用交联透明质酸钠凝胶Pre-filled Cross-linked Sodium Hyaluronate Syringe
Registrant
汇美迪斯株式会社Humedix Co., Ltd.
China agent
成都尚礼汇美生物科技有限公司
First approval
2026-06-16
This certificate issued
2026-06-16
Valid until
2031-06-15
Models and sizes
Rephoria HARA – L
Checked against official page
2026-10-23

Public: fields from the registration record.

Label facts by jurisdiction

What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A

No data yet

Registration timeline

  1. CN

    国械注进20263130223 first approved

  2. CN

    国械注进20263130223 change

    首次获批(受理号 JQZ2400616;2026年06月17日医疗器械批准证明文件送达信息)

  3. CN

    国械注进20263130223 valid until

First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record.

Cross findings · Price observations

Sign in to see findings and prices

Findings and prices stay out of indexable pages.

Sign in to view

Recent changes

1
  • 国械注进20263130223: 首次获批(受理号 JQZ2400616;2026年06月17日医疗器械批准证明文件送达信息)2026-06-16

Sources

1